1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. MINERALYS THERAPEUTICS INC
Mineralys Therapeutics Inc XNAS: MLYS

Mineralys Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

about

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administere...

Read More
14.49 0.61 (4.39%)
75.85% Gain from 52W Low
666.1K
XNAS Volume

XNAS 30 Jul, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Durability score
Not Eligible
-
Valuation Score
Expensive Valuation
7.2 / 100
Momentum Score
Technically Neutral
58.5 / 100
Analyst Price Target
No estimates available

10

S

5

W

5

O

0

T

SWOT Analysis

Mineralys Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..